Understanding how blood stem cells divide and develop
Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions
This study is looking at how blood stem cells decide whether to make more stem cells or turn into different types of blood cells, which could help find new treatments for blood-related diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11144633 on NIH RePORTER |
What this research studies
This research investigates the mechanisms that control how hematopoietic stem cells (HSCs) divide and differentiate into various blood cells. By using advanced techniques like FATE-seq, the study aims to identify the molecular programs that dictate whether these stem cells self-renew or commit to becoming specialized blood cells. The research focuses on the role of specific RNA modifications and proteins in regulating these division choices, which are crucial for maintaining healthy blood cell levels. Patients may benefit from insights gained that could lead to new treatments for blood-related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with hematologic diseases or conditions affecting blood cell production.
Not a fit: Patients with non-hematologic conditions or those not affected by blood diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for hematologic diseases by improving our understanding of blood stem cell behavior.
How similar studies have performed: Other research has shown promising results in understanding stem cell behavior, making this approach both relevant and potentially impactful.
Where this research is happening
Philadelphia, United States
- Research Inst of Fox Chase Can Ctr — Philadelphia, United States (Active)
Researchers
- Principal investigator: Luo, Hanzhi — Research Inst of Fox Chase Can Ctr
- Study coordinator: Luo, Hanzhi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.